Advertisement
SIGA 외환 뉴스
SIGA Technologies Says Oral Tecovirimat Approved In The U.K. To Treat Monkeypox
Pharmaceutical company SIGA Technologies, Inc. (SIGA) announced Friday that the U.K. has approved its oral tecovirimat for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications following vaccination against smallpox in adults and children with a body weight of at least 13kg.
RTTNews
|
1526 일 전
